Details for Patent: 4,379,454

Summary for Patent: 4,379,454

Title:	Dosage for coadministering drug and percutaneous absorption enhancer
Abstract:	A dosage form that coadministers a drug and a percutaneous absorption enhancer to a defined area of the skin. The dosage form comprises a body that contains supplies of drug and enhancer and has a basal surface that contacts the area of skin and transmits the drug and enhancer to the area for absorption thereby. The drug is provided to the basal surface at a rate at least as great as the rate at which the skin is able to absorb the drug whereas the enhancer is via a rate controlling means at a substantially constant rate that increases the permeability of the treated area of skin to the drug to a level at which the drug is absorbed at a therapeutically effective rate.
Inventor(s):	Campbell; Patricia S. (Palo Alto, CA), Chandrasekaran; Santosh K. (Palo Alto, CA)
Assignee:	ALZA Corporation (Palo Alto, CA)
Application Number:	06/235,068
Patent Claim Types: see list of patent claims	Dosage form; Composition; Use;

Drugs Protected by US Patent 4,379,454

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

International Family Members for US Patent 4,379,454

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	4502085
Australia	547007
Australia	565178
Australia	7954582